Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease

Journal of Cystic Fibrosis

Volumn 16, Issue 1, 2017, Pages 98-106

  Decorte, N ^a,b   Gruet, M ^a,b,c   Camara, B ^e   Quetant, S ^e   Mely, L ^c,d   Vallier, J M ^c   Verges, S ^a,b   Wuyam, B ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b INSERM   (France)

^c University of Nice Sophia Antipolis   (France)

^d Renée Sabran Hospital   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

31P MR spectroscopy; Cystic fibrosis; Exercise tolerance; Muscle metabolism

Indexed keywords

CREATINE PHOSPHATE; PHOSPHORUS;

ADULT; ADULT DISEASE; AMINO ACID SYNTHESIS; ARTICLE; CELL PH; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; CYSTIC FIBROSIS; DAILY LIFE ACTIVITY; ENERGY TRANSFER; EXHAUSTION; FEMALE; FLEXOR MUSCLE; GASTROCNEMIUS MUSCLE; HUMAN; LUNG DISEASE; MALE; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL ACTIVITY; WALKING; WORKLOAD; COMPLICATION; ENERGY METABOLISM; EXERCISE TEST; EXERCISE TOLERANCE; LOWER LIMB; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PATIENT ACUITY; PROCEDURES; SKELETAL MUSCLE; STATISTICS;

ADULT; CYSTIC FIBROSIS; ENERGY METABOLISM; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LOWER EXTREMITY; LUNG DISEASES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PATIENT ACUITY; STATISTICS AS TOPIC;

EID: 85006373192     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2016.05.010     Document Type: Article

References (47)

1. [1] Hebestreit, H., Schmid, K., Kieser, S., Junge, S., Ballmann, M., Roth, K., et al. Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulm Med, 14, 2014, 26.
2. [2] Pianosi, P., Leblanc, J., Almudevar, A., Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 60 (2005), 50–54.
3. [3] Moorcroft, A.J., Dodd, M.E., Morris, J., Webb, A.K., Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis. Eur Respir J 25 (2005), 1050–1056.
4. [4] Vallier, J.M., Gruet, M., Mely, L., Pensini, M., Brisswalter, J., Neuromuscular fatigue after maximal exercise in patients with cystic fibrosis. J Electromyogr Kinesiol 21 (2011), 242–248.
5. [5] Lamhonwah, A.M., Bear, C.E., Huan, L.J., Kim Chiaw, P., Ackerley, C.A., Tein, I., Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 67 (2010), 802–808.
6. [6] Tu, J., Le, G., Ballard, H.J., Involvement of the cystic fibrosis transmembrane conductance regulator in the acidosis-induced efflux of ATP from rat skeletal muscle. J Physiol 588 (2010), 4563–4578.
7. [7] Li, C., Ramjeesingh, M., Wang, W., Garami, E., Hewryk, M., Lee, D., et al. ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 271 (1996), 28463–28468.
8. [8] Gruet, M., Decorte, N., Mely, L., Vallier, J.M., Camara, B., Quetant, S., et al. Skeletal muscle contractility and fatigability in adults with cystic fibrosis. J Cyst Fibros 15 (2016), e1–e8.
9. [9] Mammen, A.L., Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 7 (2011), 343–354.
10. [10] Shields, G.S., Coissi, G.S., Jimenez-Royo, P., Gambarota, G., Dimber, R., Hopkinson, N.S., et al. Bioenergetics and intermuscular fat in chronic obstructive pulmonary disease-associated quadriceps weakness. Muscle Nerve 51 (2015), 214–221.
11. [11] Selvadurai, H.C., Allen, J., Sachinwalla, T., Macauley, J., Blimkie, C.J., Van Asperen, P.P., Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 168 (2003), 1476–1480.
12. [12] de Meer, K., Jeneson, J.A., Gulmans, V.A., van der Laag, J., Berger, R., Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax 50 (1995), 980–983.
13. [13] Wells, G.D., Wilkes, D.L., Schneiderman, J.E., Rayner, T., Elmi, M., Selvadurai, H., et al. Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res 69 (2011), 40–45.
14. [14] Werkman, M., Jeneson, J., Helders, P., Arets, B., van der Ent, K., Velthuis, B., et al. Exercise oxidative skeletal muscle metabolism in adolescents with cystic fibrosis. Exp Physiol, 2015.
15. [15] Plant, B.J., Goss, C.H., Plant, W.D., Bell, S.C., Management of comorbidities in older patients with cystic fibrosis. Lancet Respir Med 1 (2013), 164–174.
16. [16] de Meer, K., Gulmans, V.A., van Der Laag, J., Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 159 (1999), 748–754.
17. [17] Ratel, S., Martin, V., Tonson, A., Cozzone, P.J., Bendahan, D., Can we simply infer mitochondrial function from PCr resynthesis after exercise in skeletal muscle?. Pediatr Res, 72, 2012, 221.
18. [18] Bendahan, D., Giannesini, B., Cozzone, P.J., Functional investigations of exercising muscle: a noninvasive magnetic resonance spectroscopy-magnetic resonance imaging approach. Cell Mol Life Sci 61 (2004), 1001–1015.
19. [19] Baecke, J.A., Burema, J., Frijters, J.E., A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36 (1982), 936–942.
20. [20] Karila, C., Ravilly, S., Gauthier, R., Tardif, C., Neveu, H., Maire, J., et al. Physical activity and exercise training for patients with cystic fibrosis. Rev Mal Respir 27 (2010), 301–313.
21. [21] Henry, B., Aussage, P., Grosskopf, C., Goehrs, J.M., Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 12 (2003), 63–76.
22. [22] Vivodtzev, I., Decorte, N., Wuyam, B., Gonnet, N., Durieu, I., Levy, P., et al. Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. Chest 143 (2013), 485–493.
23. [23] Ratel, S., Tonson, A., Cozzone, P.J., Bendahan, D., The rate of PCr resynthesis is not a reliable index of skeletal muscle oxidative capacity. Eur J Appl Physiol 114 (2014), 217–218.
24. 31P-MRS study. Magn Reson Med 62 (2009), 840–854.
25. 31P magnetic resonance spectroscopy of (human) skeletal muscle. Proc Nutr Soc 58 (1999), 861–870.
26. [26] Naressi, A., Couturier, C., Castang, I., de Beer, R., Graveron-Demilly, D., Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 31 (2001), 269–286.
27. 31P nuclear magnetic resonance study. Mol Biol Med 1 (1983), 77–94.
28. 31P magnetic resonance spectroscopy. J Physiol 535 (2001), 901–928.
29. [29] Iotti, S., Frassineti, C., Alderighi, L., Sabatini, A., Vacca, A., Barbiroli, B., In vivo (31)P-MRS assessment of cytosolic [Mg(2 +)] in the human skeletal muscle in different metabolic conditions. Magn Reson Imaging 18 (2000), 607–614.
30. 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise. NMR Biomed 6 (1993), 248–253.
31. 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q 10 (1994), 43–63.
32. [32] Layec, G., Haseler, L.J., Richardson, R.S., The effect of higher ATP cost of contraction on the metabolic response to graded exercise in patients with chronic obstructive pulmonary disease. J Appl Physiol 112 (2012), 1041–1048.
33. [33] Layec, G., Trinity, J.D., Hart, C.R., Hopker, J., Passfield, L., Coen, P.M., et al. Comments on point: counterpoint: Skeletal muscle mechanical efficiency does/does not increase with age. J Appl Physiol 114 (2013), 1114–1118.
34. 31P magnetic resonance spectroscopy study of phosphocreatine recovery kinetics in skeletal muscle: the issue of intersubject variability. Biochim Biophys Acta 1457 (2000), 18–26.
35. [35] Sweezey, N.B., Ratjen, F., The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol 49 (2014), 309–317.
36. [36] Erickson, M.L., Seigler, N., McKie, K.T., McCully, K.K., Harris, R.A., Skeletal muscle oxidative capacity in patients with cystic fibrosis. Exp Physiol 100 (2015), 545–552.
37. 31P-NMRS in humans. J Appl Physiol 94 (2003), 1012–1024.
38. 31P MRS in sprint and endurance athletes and untrained individuals. Int J Sports Med 34 (2013), 669–675.
39. [39] Pinet, C., Cassart, M., Scillia, P., Lamotte, M., Knoop, C., Casimir, G., et al. Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med 168 (2003), 989–994.
40. [40] Barry, S.C., Gallagher, C.G., Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 95 (2003), 1379–1384.
41. [41] Burtin, C., Van Remoortel, H., Vrijsen, B., Langer, D., Colpaert, K., Gosselink, R., et al. Impact of exacerbations of cystic fibrosis on muscle strength. Respir Res, 14, 2013, 46.
42. [42] Dufresne, V., Knoop, C., Van Muylem, A., Malfroot, A., Lamotte, M., Opdekamp, C., et al. Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis. Am J Respir Crit Care Med 180 (2009), 153–158.
43. [43] Divangahi, M., Balghi, H., Danialou, G., Comtois, A.S., Demoule, A., Ernest, S., et al. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet, 5, 2009, e1000586.
44. [44] Troosters, T., Langer, D., Vrijsen, B., Segers, J., Wouters, K., Janssens, W., et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 33 (2009), 99–106.
45. [45] Savi, D., Quattrucci, S., Internullo, M., De Biase, R.V., Calverley, P.M., Palange, P., Measuring habitual physical activity in adults with cystic fibrosis. Respir Med 107 (2013), 1888–1894.
46. [46] Philippaerts, R.M., Westerterp, K.R., Lefevre, J., Doubly labelled water validation of three physical activity questionnaires. Int J Sports Med 20 (1999), 284–289.
47. [47] Pitta, F., Troosters, T., Probst, V.S., Spruit, M.A., Decramer, M., Gosselink, R., Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 27 (2006), 1040–1055.